Production (Stage)
bluebird bio, Inc.
BLUE
$4.98
-$0.02-0.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.50% | 262.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.50% | 262.99% | |||
| Cost of Revenue | -46.30% | 93.44% | |||
| Gross Profit | 68.29% | 1,445.77% | |||
| SG&A Expenses | -3.80% | -19.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.74% | 0.41% | |||
| Operating Income | 41.09% | 43.05% | |||
| Income Before Tax | -1.27% | 53.00% | |||
| Income Tax Expenses | -6.54% | 284.48% | |||
| Earnings from Continuing Operations | -1.24% | 52.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.24% | 52.78% | |||
| EBIT | 41.09% | 43.05% | |||
| EBITDA | 73.61% | 53.65% | |||
| EPS Basic | -0.90% | 52.89% | |||
| Normalized Basic EPS | 23.59% | 50.76% | |||
| EPS Diluted | -0.90% | 52.89% | |||
| Normalized Diluted EPS | 23.59% | 50.76% | |||
| Average Basic Shares Outstanding | 0.34% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||